Pelvic CT with Agatston Calcium Score for Peyronie Disease
NCT05480683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-09-19
Summary
The purpose of this study is to find out how including a CT exam of the penis can help urologists make treatment decisions for patients with calcified Peyronie's disease.
Conditions
- Peyronie Disease
Interventions
- DIAGNOSTIC_TEST
-
CT exam
Noncontrast CT of the pelvis with specific penile anatomical positioning for coverage and with the protocol optimized for application of Agatston calcium scoring post processing.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Lauren Alexander, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-04
- Primary Completion
- 2024-01-17
- Completion
- 2024-01-17
Countries
- United States
Study Locations
More Related Trials
-
The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer
NCT04936334 ·Status: COMPLETED ·Phase: PHASE2
-
Expanded Access [Ga-68] PSMA-11 PET Imaging
NCT04800068 ·Status: NO_LONGER_AVAILABLE
-
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
NCT05002465 ·Status: NO_LONGER_AVAILABLE
-
Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
NCT02501759 ·Status: TERMINATED ·Phase: NA
-
Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT04348682 ·Status: APPROVED_FOR_MARKETING
-
Image Guided Penile Cancer Surgery
NCT05376202 ·Status: COMPLETED ·Phase: PHASE1
-
Prostate Mechanical Imager (PMI) Clinical Bridging Study
NCT00822952 ·Status: COMPLETED
-
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer
NCT05547386 ·Status: COMPLETED ·Phase: PHASE3
-
C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer
NCT02715583 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
68Ga-XACP3 PET/CT in Prostate Cancer
NCT07242014 ·Status: RECRUITING ·Phase: NA
-
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge
NCT05489341 ·Status: COMPLETED
-
CMT-07-08: The PROstate Bed Evaluation Study
NCT00763152 ·Status: COMPLETED
-
Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization
NCT03440554 ·Status: UNKNOWN ·Phase: NA
-
Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II
NCT00250224 ·Status: COMPLETED ·Phase: PHASE1
-
Ga-68-PSMA-11 in High-risk Prostate Cancer
NCT03362359 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Transpelvic Magnetic Stimulation to Improve Urogenital Function
NCT04488068 ·Status: COMPLETED ·Phase: NA
-
Stratagen Quantitative Prostate MRI Platform Pilot Study
NCT06985238 ·Status: RECRUITING ·Phase: NA
-
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT
NCT05879913 ·Status: RECRUITING ·Phase: NA
-
Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study
NCT01551576 ·Status: COMPLETED
-
Transrectal Photoacoustic Imaging of the Prostate
NCT02365883 ·Status: TERMINATED
-
Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy
NCT03013413 ·Status: COMPLETED ·Phase: NA
-
Semen Analysis After Proton Therapy for Prostate Cancer
NCT01072513 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
NCT00499421 ·Status: COMPLETED
-
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
NCT04981223 ·Status: COMPLETED ·Phase: NA
-
The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction
NCT05109208 ·Status: RECRUITING ·Phase: NA